Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05382975 · ClinicalTrials.gov registry record · NA

A Comprehensive Trauma-sensitive Approach to Physical Activity Promotion in Schools (CSPAP-T)

A NA study of Physical Activity, sponsored by Seattle Children's Hospital.

Recruiting
Registry status
NA
Development phase
8,000
Enrollment target
1
Study location

NCT05382975 is a NA study of Physical Activity that is actively recruiting participants, run by Seattle Children's Hospital. The registered enrollment target is 8,000 participants, above the 297-participant average among 131 other Physical Activity trials with a reported enrollment target (2594% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05382975, a NA study of Physical Activity, is actively recruiting participants, sponsored by Seattle Children's Hospital.

RECRUITING
Registry status
NA
Development phase
8,000 participants
Enrollment target
1
Study location

Study Summary

Investigators will conduct a hybrid implementation-effectiveness trial of a trauma-adapted Comprehensive School Physical Activity Program (CSPAP) intervention. A clustered stepped wedge design will be used, with the duration of the trial being 3 years.

Conditions Studied

Interventions

  • BEHAVIORAL CSPAP-T

Study Locations (1)

Washington

  • Seattle Children's Research Institute - Seattle

Trial Details

FieldValue
Enrollment Target 8,000 participants
Start Date 2022-08-01
Est. Completion 2026-12-31
Phase NA

Sponsor

Seattle Children's Hospital

168 total trials

What the Registry Record Tells You About NCT05382975

The ClinicalTrials.gov registry entry for NCT05382975 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 8,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 297-participant average among 131 other Physical Activity trials with a reported enrollment target (2594% higher). The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Physical Activity appearing as the primary indexed condition, and to 1 intervention - of which CSPAP-T is the first listed.

NCT05382975 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT05382975 about?

NCT05382975 is a clinical study titled "A Comprehensive Trauma-sensitive Approach to Physical Activity Promotion in Schools (CSPAP-T)". Investigators will conduct a hybrid implementation-effectiveness trial of a trauma-adapted Comprehensive School Physical Activity Program (CSPAP) intervention. A clustered stepped wedge design will be used, with the duration of the trial being 3 years.

What is the current status of trial NCT05382975?

This trial is currently recruiting. It is a NA study. The enrollment target is 8,000 participants. The study started on 2022-08-01. Estimated completion is 2026-12-31.

What conditions does trial NCT05382975 study?

This clinical trial studies the following conditions: Physical Activity.

What interventions are being tested in trial NCT05382975?

The interventions under investigation include: CSPAP-T (BEHAVIORAL).

Who is sponsoring clinical trial NCT05382975?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05382975 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Physical Activity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.